Stocks · News reference
Eupraxia Pharmaceuticals Q2 EPS $(0.23) Beats $(0.25) Estimate
Eupraxia Pharmaceuticals (TSX:EPRX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent. This is a 11.54 percent increase over losses of $(0.26) per share
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 9:50 PM
- Checked
- Aug 11, 2026, 9:50 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
No Linked Headlines Yet
The feed will populate when a captured headline is linked to this market.